Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Yahoo Finance3d
Is a New AI Model the Catalyst Alphabet Stock Needed?
Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question its position in the artificial intelligence (AI) landscape ...
Yahoo Finance3d
Alphabet Inc. (GOOGL)’s AI Powers Lockheed Martin’s National Security Innovations
We recently published a list of 10 AI Stocks Dominating the News This Week. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against other AI stocks ...
Business Insider13d
Alphabet (GOOGL) Is the Best Bet in AI Search, Says Five-Star Analyst
Despite rising competitive threats, Google parent company Alphabet (GOOGL) is still investors best bet when it comes to artificial intelligence-enabled (AI) search engines, says a top Wall Street ...
Crunchbase News1d
Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Google-Backed AI Drug Discovery Startup Raises $600 Million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.